| pubmed-article:11459202 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11459202 | lifeskim:mentions | umls-concept:C0027819 | lld:lifeskim |
| pubmed-article:11459202 | lifeskim:mentions | umls-concept:C0032207 | lld:lifeskim |
| pubmed-article:11459202 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:11459202 | lifeskim:mentions | umls-concept:C0439855 | lld:lifeskim |
| pubmed-article:11459202 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:11459202 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
| pubmed-article:11459202 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
| pubmed-article:11459202 | lifeskim:mentions | umls-concept:C1515655 | lld:lifeskim |
| pubmed-article:11459202 | lifeskim:mentions | umls-concept:C0756613 | lld:lifeskim |
| pubmed-article:11459202 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:11459202 | pubmed:dateCreated | 2001-7-18 | lld:pubmed |
| pubmed-article:11459202 | pubmed:abstractText | BBR 3464 is a promising new trinuclear platinum complex that has been shown to circumvent the resistance to cisplatin in a panel of tumor cell lines and xenografts with acquired or intrinsic resistance to cisplatin. The in vitro and in vivo antitumor activity of BBR 3464 was evaluated and compared with that of cisplatin in neuroblastoma. | lld:pubmed |
| pubmed-article:11459202 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11459202 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11459202 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11459202 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11459202 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11459202 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11459202 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11459202 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11459202 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11459202 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:11459202 | pubmed:issn | 0344-5704 | lld:pubmed |
| pubmed-article:11459202 | pubmed:author | pubmed-author:SegniGG | lld:pubmed |
| pubmed-article:11459202 | pubmed:author | pubmed-author:RiccardiAA | lld:pubmed |
| pubmed-article:11459202 | pubmed:author | pubmed-author:RiccardiRR | lld:pubmed |
| pubmed-article:11459202 | pubmed:author | pubmed-author:CarelliGG | lld:pubmed |
| pubmed-article:11459202 | pubmed:author | pubmed-author:MeclAA | lld:pubmed |
| pubmed-article:11459202 | pubmed:author | pubmed-author:ServideiTT | lld:pubmed |
| pubmed-article:11459202 | pubmed:author | pubmed-author:ManzottiCC | lld:pubmed |
| pubmed-article:11459202 | pubmed:author | pubmed-author:FerliniCC | lld:pubmed |
| pubmed-article:11459202 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11459202 | pubmed:volume | 47 | lld:pubmed |
| pubmed-article:11459202 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11459202 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11459202 | pubmed:pagination | 498-504 | lld:pubmed |
| pubmed-article:11459202 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11459202 | pubmed:meshHeading | pubmed-meshheading:11459202... | lld:pubmed |
| pubmed-article:11459202 | pubmed:meshHeading | pubmed-meshheading:11459202... | lld:pubmed |
| pubmed-article:11459202 | pubmed:meshHeading | pubmed-meshheading:11459202... | lld:pubmed |
| pubmed-article:11459202 | pubmed:meshHeading | pubmed-meshheading:11459202... | lld:pubmed |
| pubmed-article:11459202 | pubmed:meshHeading | pubmed-meshheading:11459202... | lld:pubmed |
| pubmed-article:11459202 | pubmed:meshHeading | pubmed-meshheading:11459202... | lld:pubmed |
| pubmed-article:11459202 | pubmed:meshHeading | pubmed-meshheading:11459202... | lld:pubmed |
| pubmed-article:11459202 | pubmed:meshHeading | pubmed-meshheading:11459202... | lld:pubmed |
| pubmed-article:11459202 | pubmed:meshHeading | pubmed-meshheading:11459202... | lld:pubmed |
| pubmed-article:11459202 | pubmed:meshHeading | pubmed-meshheading:11459202... | lld:pubmed |
| pubmed-article:11459202 | pubmed:meshHeading | pubmed-meshheading:11459202... | lld:pubmed |
| pubmed-article:11459202 | pubmed:meshHeading | pubmed-meshheading:11459202... | lld:pubmed |
| pubmed-article:11459202 | pubmed:meshHeading | pubmed-meshheading:11459202... | lld:pubmed |
| pubmed-article:11459202 | pubmed:meshHeading | pubmed-meshheading:11459202... | lld:pubmed |
| pubmed-article:11459202 | pubmed:meshHeading | pubmed-meshheading:11459202... | lld:pubmed |
| pubmed-article:11459202 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11459202 | pubmed:articleTitle | In vitro and in vivo antitumor activity of the novel trinuclear platinum complex BBR 3464 in neuroblastoma. | lld:pubmed |
| pubmed-article:11459202 | pubmed:affiliation | Department of Paediatrics, Catholic University of Rome, Italy. | lld:pubmed |
| pubmed-article:11459202 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11459202 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11459202 | lld:pubmed |
